Sarah Batson, Allan Hackshaw, Anne Mackie, Mike Richards, Rosalind Given-Wilson, Emma Atakpa, Edmund Njeru Njagi, Bethany Shinkins, Tom Callender, Chris Hyde, Cristina Visintin, David Thompson, Eleanor Cozens, Gareth Evans, Karla Hemming, K. Payne, Steve Halligan, Sian Taylor-Phillips
Surrogate outcomes may offer earlier evidence of benefit and initiate further evaluative work, but they cannot yet replace mortality as the definitive outcome in cancer screening trials, say Sian Taylor-Phillips and colleagues